Wilson Sonsini Goodrich & Rosati advised Emboline on the deal. Emboline, Inc., a privately held medical device company focused on reducing stroke and other damage caused...
Emboline’s $55 Million Series D Funding
Relativity’s Acquisition of Text IQ
Wilson Sonsini Goodrich & Rosati advised Relativity on the deal. Relativity, a global legal and compliance technology company, announced that it has acquired Text IQ, a...
Symphony Technology Group’s $1.2 Billion Acquisition of FireEye Products Business
Paul Hastings LLP advised Symphony Technology Group on the deal while Wilson Sonsini Goodrich & Rosati represented FireEye. Symphony Technology Group, a private equity firm focused...
Wayflyer’s $76 Million Series A Funding
Wilson Sonsini Goodrich & Rosati advised Wayflyer on the deal, while Matheson acted for Left Lane Capital and DST Global. Wayflyer, a revenue-based financing and growth...
Paymentus’ IPO and Concurrent Private Placement
Wilson Sonsini Goodrich & Rosati advised Paymentus on the deal, while Davis Polk advised the representatives of the several underwriters. Paymentus, a leading provider of cloud-based...
Paysend’s $125 Million Series B Funding
Wilson Sonsini Goodrich & Rosati advised Paysend on the deal. London-based fintech start-up Paysend announced that it has closed a $125 million Series B funding round....
Yoto Limited’s $17 million Series A Funding
CMS advised Acton Capital on the deal. Taylor Wessing and Wilson Sonsini Goodrich & Rosati advised Yoto. Acton Capital acted as lead investor on the $17 million...
Snap Inc.’s $500 Million Acquisition of WaveOptics
Wilson Sonsini Goodrich & Rosati and RPC advised WaveOptics on the deal. Snap Inc. announced that it will acquire WaveOptics Ltd, a British augmented reality (AR)...
Cervest’s $30 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Cervest on the deal. London-based Cervest, creator of the world’s first AI-powered Climate Intelligence (CI) platform, announced that it has...
Aerpio Pharmaceuticals’ Merger with Aadi Bioscience
Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their...
Forge Biologics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
Capsigen’s Research Collaboration with Biogen
Wilson Sonsini Goodrich & Rosati advised Capsigen Inc. on the deal. Biogen Inc. and Capsigen Inc. announced they have entered into a strategic research collaboration to...